Websites selling AMH “fertility” tests use false or misleading claims, researchers find

Tests for the anti-müllerian hormone (AMH) are being marketed as measures of fertility using claims that could lead to “misplaced anxiety or reassurance” and could change people’s plans for contraception or conception, researchers have warned.1

A research team based in Australia identified 27 websites in the US, India, UK, Canada, Ireland, the Netherlands, and Australia that sold direct-to-consumer AMH tests. They said that, despite evidence that the test cannot reliably predict current or future fertility, three quarters (20) of the …